VVOS to announce strategic partnership by Q1 2027
Resolves: VVOS will announce a new strategic partnership or licensing agreement in a press release.
sec_filing· Corporate Governance
VVOS to announce strategic partnership by Q1 2027
Market overview
Derived from Vivos Therapeutics, Inc. (VVOS) (CIK 0001716166) 8-K filing analysis
Corporate Governance prediction market
- Implied probability (Yes)
- 65%
- Closes
- 2027-01-21
About this prediction
Resolution criteria
VVOS will announce a new strategic partnership or licensing agreement in a press release.
More Corporate Governance markets
- Will PEBO declare a cash dividend in January 2027? — 85% Yes
- Executive C-suite departure within 12 months — 30% Yes
- Will any of the newly appointed board members resign within 14 months? — 40% Yes
- New Board of Directors post-AZIO AI HOLDINGS, INC. Merger — 55% Yes
- Dividend maintained at $0.60 for Q1 2027 — 85% Yes
- Permanent executive appointments by Q1 2027 — 75% Yes
- CFO Retention for 90 Days — 85% Yes
- Will shareholders approve the merger agreement at the special meeting? — 80% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…